3 August 2026
FDA fast-tracks remlifanserin for Alzheimer’s psychosis
Acadia Pharmaceuticals expects Phase 2 RADIANT topline results in September or October 2026.
source: alzheimersnewstoday.com
The full briefing is in the app.
3 August 2026
Acadia Pharmaceuticals expects Phase 2 RADIANT topline results in September or October 2026.
source: alzheimersnewstoday.com
The full briefing is in the app.